Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syntocinon for emotional and social deficits in Asperger syndrome
2006-006126-25Phase 3Completed
- Sponsor
- CNRS: VAN DER REST Michel
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in Asperger syndrome (2 arms), sponsored by CNRS: VAN DER REST Michel. Primary endpoints: Eye contact, Emotion recognition and 2 more. Started Apr 2007; status: completed.
02
Drugs
oxytocin
03
Conditions
Asperger syndrome
Beyond the preview
Go deeper on 2006-006126-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006126-25.